The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumaraguru, U.
Right arrow Articles by Rouse, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumaraguru, U.
Right arrow Articles by Rouse, B. T.
The Journal of Immunology, 2000, 165: 750-759.
Copyright © 2000 by The American Association of Immunologists

Involvement of an ATP-Dependent Peptide Chaperone in Cross-Presentation After DNA Immunization1

Udayasankar Kumaraguru*, Richard J. D. Rouse{ddagger}, Smita K. Nair§, Barry D. Bruce{dagger} and Barry T. Rouse2,*

Departments of * Microbiology and {dagger} Biochemistry, Cellular and Molecular Biology, University of Tennessee, Knoxville, TN 37996; {ddagger} Department of Molecular Genetics and Biochemistry, University of Pittsburgh, Pittsburgh, PA 15261; and § Center for Cellular and Genetic Therapy, Department of Surgery, Duke University, Durham, NC 27710

Immunization with plasmid DNA holds promise as a vaccination strategy perhaps useful in situations that currently lack vaccines, since the major means of immune induction may differ from more conventional approach. In the present study, we demonstrate that exposure of macrophages to plasmid DNA encoding viral proteins or OVA generates Ag-specific material that, when presented in vitro by dendritic cells to naive T cells, induces primary CTL response or elicits IL-2 production from an OVA peptide-specific T-T hybridoma. The immunogenic material released was proteinaceous in nature, free of apoptotic bodies, and had an apparent m.w. much larger than a 9–11-aa CTL-recognizable peptide. The macrophage-released factor(s) specifically required a hydrolyzable ATP substrate and was inhibited by procedures that removed or hydrolyzed ATP; in addition, anti-heat-shock protein 70 antiserum abrogated the activity to a large extent. These results indicate the possible involvement of a heat-shock protein 70-linked peptide chaperone in a cross-priming method of immune induction by DNA vaccination. Such a cross-priming process may represent a principal mechanism by which plasmid DNA delivered to cells such as myocytes effectively shuttle Ag to DC or other APC to achieve CTL induction in vivo.




This article has been cited by other articles:


Home page
J. Virol.Home page
M. Chen, C. Barnfield, T. I. Naslund, M. N. Fleeton, and P. Liljestrom
MyD88 Expression Is Required for Efficient Cross-Presentation of Viral Antigens from Infected Cells
J. Virol., March 1, 2005; 79(5): 2964 - 2972.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Schirmbeck, N. Fissolo, P. Chaplin, and J. Reimann
Enhanced Priming of Multispecific, Murine CD8+ T Cell Responses by DNA Vaccines Expressing Stress Protein-Binding Polytope Peptides
J. Immunol., August 1, 2003; 171(3): 1240 - 1246.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Stebbing, B. Gazzard, L. Kim, S. Portsmouth, A. Wildfire, I. Teo, M. Nelson, M. Bower, F. Gotch, S. Shaunak, et al.
The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors
Blood, May 15, 2003; 101(10): 4000 - 4004.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
U. Kumaraguru, C. D. Pack, and B. T. Rouse
Toll-like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins
J. Leukoc. Biol., May 1, 2003; 73(5): 574 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Rush, T. Mitchell, and P. Garside
Efficient Priming of CD4+ and CD8+ T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways
J. Immunol., November 1, 2002; 169(9): 4951 - 4960.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Kammerer, D. Stober, P. Riedl, C. Oehninger, R. Schirmbeck, and J. Reimann
Noncovalent Association with Stress Protein Facilitates Cross-Priming of CD8+ T Cells to Tumor Cell Antigens by Dendritic Cells
J. Immunol., January 1, 2002; 168(1): 108 - 117.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. H. Cho, J. W. Youn, and Y. C. Sung
Cross-Priming as a Predominant Mechanism for Inducing CD8+ T Cell Responses in Gene Gun DNA Immunization
J. Immunol., November 15, 2001; 167(10): 5549 - 5557.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Eo, U. Kumaraguru, and B. T. Rouse
Plasmid DNA Encoding CCR7 Ligands Compensate for Dysfunctional CD8+ T Cell Responses by Effects on Dendritic Cells
J. Immunol., October 1, 2001; 167(7): 3592 - 3599.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Eo, M. Gierynska, A. A. Kamar, and B. T. Rouse
Prime-Boost Immunization with DNA Vaccine: Mucosal Route of Administration Changes the Rules
J. Immunol., May 1, 2001; 166(9): 5473 - 5479.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. K. Eo, S. Lee, S. Chun, and B. T. Rouse
Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines
J. Virol., January 15, 2001; 75(2): 569 - 578.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
U. Kumaraguru, I. A. Davis, S. Deshpande, S. S. Tevethia, and B. T. Rouse
Lymphotoxin {{alpha}}-/- Mice Develop Functionally Impaired CD8+ T Cell Responses and Fail to Contain Virus Infection of the Central Nervous System
J. Immunol., January 15, 2001; 166(2): 1066 - 1074.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.